RSLS
Price
$1.12
Change
-$0.11 (-8.94%)
Updated
Feb 21 closing price
Capitalization
4.33M
SMLR
Price
$47.74
Change
-$4.50 (-8.61%)
Updated
Feb 21 closing price
Capitalization
203.76M
79 days until earnings call
Ad is loading...

RSLS vs SMLR

Header iconRSLS vs SMLR Comparison
Open Charts RSLS vs SMLRBanner chart's image
ReShape Lifesciences
Price$1.12
Change-$0.11 (-8.94%)
Volume$2.37M
Capitalization4.33M
Semler Scientific
Price$47.74
Change-$4.50 (-8.61%)
Volume$285.61K
Capitalization203.76M
RSLS vs SMLR Comparison Chart
Loading...
RSLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RSLS vs. SMLR commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSLS is a Hold and SMLR is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (RSLS: $1.12 vs. SMLR: $47.74)
Brand notoriety: RSLS and SMLR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: RSLS: 194% vs. SMLR: 62%
Market capitalization -- RSLS: $4.33M vs. SMLR: $203.76M
RSLS [@Medical Specialties] is valued at $4.33M. SMLR’s [@Medical Specialties] market capitalization is $203.76M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RSLS’s FA Score shows that 0 FA rating(s) are green whileSMLR’s FA Score has 0 green FA rating(s).

  • RSLS’s FA Score: 0 green, 5 red.
  • SMLR’s FA Score: 0 green, 5 red.
According to our system of comparison, SMLR is a better buy in the long-term than RSLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RSLS’s TA Score shows that 3 TA indicator(s) are bullish while SMLR’s TA Score has 2 bullish TA indicator(s).

  • RSLS’s TA Score: 3 bullish, 4 bearish.
  • SMLR’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, RSLS is a better buy in the short-term than SMLR.

Price Growth

RSLS (@Medical Specialties) experienced а -51.93% price change this week, while SMLR (@Medical Specialties) price change was -3.89% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.75%. For the same industry, the average monthly price growth was -1.45%, and the average quarterly price growth was +2.31%.

Reported Earning Dates

RSLS is expected to report earnings on May 15, 2023.

SMLR is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Medical Specialties (-1.75% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SMLR($204M) has a higher market cap than RSLS($4.33M). SMLR YTD gains are higher at: -11.593 vs. RSLS (-74.888). SMLR has higher annual earnings (EBITDA): 23.6M vs. RSLS (-36.72M). SMLR has more cash in the bank: 57.2M vs. RSLS (1.45M). SMLR has less debt than RSLS: SMLR (160K) vs RSLS (285K). SMLR has higher revenues than RSLS: SMLR (68.2M) vs RSLS (9.81M).
RSLSSMLRRSLS / SMLR
Capitalization4.33M204M2%
EBITDA-36.72M23.6M-156%
Gain YTD-74.888-11.593646%
P/E RatioN/A11.02-
Revenue9.81M68.2M14%
Total Cash1.45M57.2M3%
Total Debt285K160K178%
FUNDAMENTALS RATINGS
RSLS vs SMLR: Fundamental Ratings
RSLS
SMLR
OUTLOOK RATING
1..100
955
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
64
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10046
PRICE GROWTH RATING
1..100
9860
P/E GROWTH RATING
1..100
10094
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RSLS's Valuation (37) in the Medical Specialties industry is in the same range as SMLR (64). This means that RSLS’s stock grew similarly to SMLR’s over the last 12 months.

RSLS's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as SMLR (100). This means that RSLS’s stock grew similarly to SMLR’s over the last 12 months.

SMLR's SMR Rating (46) in the Medical Specialties industry is somewhat better than the same rating for RSLS (100). This means that SMLR’s stock grew somewhat faster than RSLS’s over the last 12 months.

SMLR's Price Growth Rating (60) in the Medical Specialties industry is somewhat better than the same rating for RSLS (98). This means that SMLR’s stock grew somewhat faster than RSLS’s over the last 12 months.

SMLR's P/E Growth Rating (94) in the Medical Specialties industry is in the same range as RSLS (100). This means that SMLR’s stock grew similarly to RSLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSLSSMLR
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
73%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 16 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 3 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
RSLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GEICX7.57-0.09
-1.17%
Gabelli Equity Income C
UIVRX12.15-0.19
-1.54%
MFS Intrinsic Value R6
CGEOX17.84-0.40
-2.19%
Calamos Global Equity R6
JCNCX24.68-0.67
-2.64%
Janus Henderson Contrarian C
CSMVX40.00-1.45
-3.50%
Congress Small Cap Growth Retail

RSLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RSLS has been loosely correlated with GENE. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RSLS jumps, then GENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSLS
1D Price
Change %
RSLS100%
-8.94%
GENE - RSLS
45%
Loosely correlated
N/A
HSCS - RSLS
35%
Loosely correlated
-3.17%
GMED - RSLS
31%
Poorly correlated
-4.56%
NARI - RSLS
30%
Poorly correlated
N/A
AZTA - RSLS
30%
Poorly correlated
-0.07%
More

SMLR and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMLR has been loosely correlated with RSLS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SMLR jumps, then RSLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMLR
1D Price
Change %
SMLR100%
-8.61%
RSLS - SMLR
44%
Loosely correlated
-8.94%
TMCI - SMLR
38%
Loosely correlated
-3.00%
RDNT - SMLR
35%
Loosely correlated
-5.11%
TRUMY - SMLR
34%
Loosely correlated
-0.68%
AXGN - SMLR
34%
Loosely correlated
-2.70%
More